EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Intraosseous platelet-rich plasma for osteoarthritis: a comprehensive review

Luis García Bordes, Roberto Seijas Vázquez, Pedro Álvarez Díaz, Anna Castelló Egea, Xavier Cuscó Segarra, David Barastegui Fernández, Miguel Vázquez Gómez, Iker Ayestaran Calero, Silvia Vizcaíno Navarro, Patricia Laiz Boada, Alfred Ferré-Aniorte, Paula Velasco Alcalde und 2 weitere

EFORT Open Reviews · 01.06.2026 · 11 (6) · 512-523

DOI: 10.1530/eor-2025-0137 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift EFORT Open Reviews, online erschienen am 01.06.2026. Verfasst von Luis García Bordes und 13 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Cugat- Quironsalud Barcelona, Barcelona, Spain. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intraosseous platelet-rich plasma (IO-PRP) therapy is an emerging biologic approach targeting the osteochondral unit in osteoarthritis (OA), especially of the knee and hip, by addressing subchondral bone pathology implicated in disease progression. This review synthesizes clinical and preclinical evidence on IO-PRP from PubMed and Scopus (up to May 2025), focusing on its biological rationale, therapeutic efficacy, and applications in osteoarticular disease. Evidence from randomized trials, observational studies, and experimental models indicates that IO-PRP – particularly when combined with intra-articular PRP – improves pain, function, and joint structure in moderate-to-severe OA. Preclinical studies demonstrate IO-PRP’s role in subchondral bone remodelling, mesenchymal stromal cell modulation, and inflammation reduction, supporting its disease-modifying potential. IO-PRP represents a promising, biologically grounded intervention for OA management; however, further standardized, long-term clinical trials are needed to determine optimal protocols and validate long-term benefits.

Schlagwörter

Stichwörter der Autor:innen

bone marrow lesionsintraosseous injectionjoint preservationorthobiologicsosteoarthritisplatelet-rich plasmasubchondral bonetissue

Autor:innen und Institutionen

  • Instituto Cugat- Quironsalud Barcelona, Barcelona, Spain.
  • CAP Pare Claret, ICS, Barcelona, Spain.

Zitieren

APA

García Bordes, L., Seijas Vázquez, R., Álvarez Díaz, P., Castelló Egea, A., Cuscó Segarra, X., Barastegui Fernández, D., Vázquez Gómez, M., Ayestaran Calero, I., Vizcaíno Navarro, S., Laiz Boada, P., Ferré-Aniorte, A., Velasco Alcalde, P., García Balletbó, M., & Cugat Bertomeu, R. (2026). Intraosseous platelet-rich plasma for osteoarthritis: a comprehensive review. EFORT Open Reviews, 11(6), 512-523. https://doi.org/10.1530/eor-2025-0137

Vancouver

García Bordes L, Seijas Vázquez R, Álvarez Díaz P, Castelló Egea A, Cuscó Segarra X, Barastegui Fernández D, et al. Intraosseous platelet-rich plasma for osteoarthritis: a comprehensive review. EFORT Open Reviews. 2026;11(6):512-523. doi:10.1530/eor-2025-0137

BibTeX
@article{GarcaBordes2026,
  author = {García Bordes, Luis and Seijas Vázquez, Roberto and Álvarez Díaz, Pedro and Castelló Egea, Anna and Cuscó Segarra, Xavier and Barastegui Fernández, David and Vázquez Gómez, Miguel and Ayestaran Calero, Iker and Vizcaíno Navarro, Silvia and Laiz Boada, Patricia and Ferré-Aniorte, Alfred and Velasco Alcalde, Paula and García Balletbó, Montserrat and Cugat Bertomeu, Ramón},
  title = {Intraosseous platelet-rich plasma for osteoarthritis: a comprehensive review},
  journal = {EFORT Open Reviews},
  year = {2026},
  volume = {11},
  number = {6},
  pages = {512--523},
  doi = {10.1530/eor-2025-0137}
}
Kostenlos starten →